| Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome A Mazzanti, R Maragna, G Vacanti, N Monteforte, R Bloise, M Marino, ... Journal of the American College of Cardiology 71 (15), 1663-1671, 2018 | 168 | 2018 |
| Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis F Conforti, L Pala, V Bagnardi, G Viale, T De Pas, E Pagan, ... JNCI: Journal of the National Cancer Institute 111 (8), 772-781, 2019 | 164 | 2019 |
| Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up S Kahler-Ribeiro-Fontana, E Pagan, F Magnoni, E Vicini, C Morigi, ... European Journal of Surgical Oncology 47 (4), 804-812, 2021 | 118 | 2021 |
| Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected … M Ruggeri, E Pagan, V Bagnardi, N Bianco, E Gallerani, K Buser, ... The breast 47, 85-92, 2019 | 106 | 2019 |
| Laryngeal cancer mortality trends in E uropean countries L Chatenoud, W Garavello, E Pagan, P Bertuccio, S Gallus, C La Vecchia, ... International Journal of Cancer 138 (4), 833-842, 2016 | 100 | 2016 |
| Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis F Conforti, L Pala, I Sala, C Oriecuia, T De Pas, C Specchia, R Graffeo, ... Bmj 375, 2021 | 83 | 2021 |
| Hydroquinidine prevents life-threatening arrhythmic events in patients with short QT syndrome A Mazzanti, R Maragna, G Vacanti, A Kostopoulou, M Marino, ... Journal of the American College of Cardiology 70 (24), 3010-3015, 2017 | 66 | 2017 |
| Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy CP Vellano, MG White, MC Andrews, M Chelvanambi, RG Witt, ... Nature 606 (7915), 797-803, 2022 | 60 | 2022 |
| Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies F Rea, E Pagan, M Monzio Compagnoni, A Cantarutti, P Pugni, ... Epidemiology Biostatistics and Public Health 14 (3), 12616-1-12616-8, 2017 | 58 | 2017 |
| Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion F Conforti, L Pala, E Pagan, V Bagnardi, T De Pas, P Queirolo, ... Clinical Cancer Research 27 (15), 4311-4324, 2021 | 54 | 2021 |
| Natural history and risk stratification in Andersen-Tawil syndrome type 1 A Mazzanti, D Guz, A Trancuccio, E Pagan, D Kukavica, T Chargeishvili, ... Journal of the American College of Cardiology 75 (15), 1772-1784, 2020 | 52 | 2020 |
| Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta … F Conforti, L Pala, E Pagan, C Corti, V Bagnardi, P Queirolo, C Catania, ... ESMO open 6 (5), 100251, 2021 | 46 | 2021 |
| Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary … S Rizzo, F De Piano, V Buscarino, E Pagan, V Bagnardi, V Zanagnolo, ... European journal of radiology 123, 108786, 2020 | 43 | 2020 |
| Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ F Magnoni, G Massari, G Santomauro, V Bagnardi, E Pagan, G Peruzzotti, ... Journal of British Surgery 106 (4), 375-383, 2019 | 41 | 2019 |
| Comparison of trends in mortality from coronary heart and cerebrovascular diseases in north and South America: 1980 to 2013 E Pagan, L Chatenoud, T Rodriguez, C Bosetti, F Levi, M Malvezzi, ... The American journal of cardiology 119 (6), 862-871, 2017 | 41 | 2017 |
| Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) A Mazzanti, A Trancuccio, D Kukavica, E Pagan, M Wang, M Mohsin, ... EP Europace 24 (4), 614-619, 2022 | 40 | 2022 |
| Metronomic chemotherapy for first-line treatment of metastatic triple-negative breast cancer: a phase II trial E Montagna, V Bagnardi, G Cancello, C Sangalli, E Pagan, M Iorfida, ... Breast Care 13 (3), 177-181, 2018 | 40 | 2018 |
| Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer L Zanotti, A Paderno, C Piazza, E Pagan, E Bignotti, C Romani, ... The Laryngoscope 127 (11), E408-E414, 2017 | 38 | 2017 |
| Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with … E Munzone, V Bagnardi, G Campennì, K Mazzocco, E Pagan, ... British journal of cancer 121 (4), 325-331, 2019 | 36 | 2019 |
| Sex-based differences of the tumor mutational burden and T-cell inflammation of the tumor microenvironment F Conforti, L Pala, V Bagnardi, G Viale, T De Pas, E Pagan, RD Gelber, ... Annals of Oncology 30 (4), 653-655, 2019 | 23 | 2019 |
